Abcentra

Private

Los Angeles, CaliforniaHealthcare & Life Scienceshttps://abcentra.com/

Company Overview

Abcentra is a clinical-stage biopharmaceutical company developing first-in-class therapeutic antibodies to treat cardiovascular inflammation by blocking oxidized LDL.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

monoclonal antibodycardiovascular inflammationbiopharmaceuticalcoronary artery diseaseCADbiotechdrug discoveryclinical trialsoxidized LDLoxLDLacute coronary syndromeACStherapeutic antibodyresidual inflammatory riskbiopharma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Abcentra Comparables

Compare Abcentra with similar companies based on industry and business-model similarity.

Abcentra comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Novartis	78%
Novo Nordisk	71%
Kiniksa Pharmaceuticals	68%

View all Comparables

Abcentra Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Chris Farina

Chief Executive Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

May 4, 2025
Grew 40% QoQ, from 10 to 14 employees.

View all signals

Abcentra Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Abcentra Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Abcentra's valuation, stock price, and market status.

Firmographic Details

HeadquartersLos Angeles, California

Employee Range15

Year Founded2005

Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.